Catheter Precision, Inc. (VTAK) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
In fiscal 2025, Catheter Precision reported revenue of $819,000, up 95.0% from $420,000 the year before. Net income was -$17.2M (a -2098.0% net margin). Gross margin was 92.3% and operating margin was -2581.6%. Operating activities generated -$8.3M of cash, leaving -$8.3M of free cash flow. At fiscal year end, Catheter Precision held $15.9M in total assets against $9.2M in total liabilities, including $88,000 of cash and equivalents.
Open the full interactive Catheter Precision financials → Quarterly statements, key ratios, valuation history and price charts.
Catheter Precision Key Stats
| Share Price | $1.06 |
|---|---|
| Market Cap | $293,349 |
| Revenue YoY Growth | +95.0% |
| 52-Week Range | $0.93 – $30.00 |
| Shares Outstanding | 276,744 (basic, 2026 Q2) |
Catheter Precision Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $4.4M | $22,000 | $14,000 | $442,000 | $420,000 | $819,000 |
| Cost of Goods Sold | $5.5M | $1.6M | $161,000 | — | $42,000 | $63,000 |
| Gross Profit | -$1.1M | -$1.5M | -$147,000 | $412,000 | $378,000 | $756,000 |
| Operating Income | -$36.1M | -$29.3M | -$27.0M | -$78.1M | -$11.2M | -$21.1M |
| Pre-Tax Income | -$36.0M | -$27.3M | -$26.9M | -$70.6M | -$13.5M | -$19.5M |
| Income Tax | $7,000 | $4,000 | $3,000 | $0 | $3.1M | -$1.8M |
| Net Income | -$36.0M | -$25.1M | -$26.9M | -$70.6M | -$16.6M | -$17.2M |
| Diluted EPS | -$2015900.00 | -$471200.00 | -$49362.00 | — | — | — |
Catheter Precision Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $226,000 | $238,000 | $432,000 | $1.0M |
| Net Income | -$2.3M | -$5.8M | -$1.7M | -$3.3M |
Catheter Precision Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $23.9M | $15.0M | $15.9M | — | $2.9M | $88,000 |
| Current Assets | $27.6M | $17.1M | $16.8M | $4.2M | $3.3M | $390,000 |
| Total Assets | $33.4M | $21.0M | $16.8M | $30.7M | $27.8M | $15.9M |
| Current Liabilities | $7.8M | $5.4M | $7.6M | $2.5M | $2.1M | $3.9M |
| Total Long-Term Debt | — | — | — | — | $1.7M | $3.1M |
| Total Liabilities | $12.3M | $7.4M | $7.6M | $9.5M | $16.0M | $9.2M |
| Shareholders' Equity | $21.1M | $13.7M | $9.3M | $21.2M | $11.8M | $7.1M |
Catheter Precision Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$28.3M | -$27.6M | -$22.6M | -$20.6M | -$9.3M | -$8.3M |
| Cash From Investing | $15.9M | $3.8M | $21,000 | -$61,000 | -$67,000 | $167,000 |
| Cash From Financing | $21.7M | $15.0M | $23.4M | $8.4M | $8.6M | $5.3M |
| Free Cash Flow | -$28.4M | -$27.9M | -$22.6M | -$20.7M | -$9.4M | -$8.3M |
Figures from Catheter Precision's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Catheter Precision financials page for every line item.
Catheter Precision Company Profile
| Ticker | VTAK |
|---|---|
| Exchange | NYSE |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | Fort Mill, South Carolina |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001716621 |
Frequently Asked Questions
What was Catheter Precision's revenue in fiscal 2025?
Catheter Precision (VTAK) reported revenue of $819,000 for fiscal 2025.
What is Catheter Precision's annual revenue history?
Catheter Precision's annual revenue by fiscal year: 2020: $4.4M; 2021: $22,000; 2022: $14,000; 2023: $442,000; 2024: $420,000; 2025: $819,000.
What was Catheter Precision's net income in fiscal 2025?
Catheter Precision reported net income of -$17.2M for fiscal 2025.
How much free cash flow did Catheter Precision generate in fiscal 2025?
Catheter Precision generated -$8.3M of free cash flow in fiscal 2025.
What was Catheter Precision's revenue last quarter?
In its most recent reported quarter (2026 Q2), Catheter Precision reported revenue of $1.0M.
How much debt does Catheter Precision have?
Catheter Precision reported $3.1M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Catheter Precision are outstanding?
Catheter Precision reported a weighted average of 276,744 basic shares outstanding in 2026 Q2.
What is Catheter Precision's market cap?
Based on its latest closing price, Catheter Precision (VTAK) has a market capitalization of about $293,349.
When does Catheter Precision's fiscal year end?
Catheter Precision's fiscal year end, as registered with the SEC, is December 31.
Where is Catheter Precision headquartered?
Catheter Precision lists its business address in Fort Mill, South Carolina in its SEC filings.
Catheter Precision Competitors & Similar Companies
See all 109 Surgical & Medical Instruments & Apparatus companies →